Your browser doesn't support javascript.
loading
Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.
Lebofsky, Ronald; Decraene, Charles; Bernard, Virginie; Kamal, Maud; Blin, Anthony; Leroy, Quentin; Rio Frio, Thomas; Pierron, Gaëlle; Callens, Céline; Bieche, Ivan; Saliou, Adrien; Madic, Jordan; Rouleau, Etienne; Bidard, François-Clément; Lantz, Olivier; Stern, Marc-Henri; Le Tourneau, Christophe; Pierga, Jean-Yves.
Afiliación
  • Lebofsky R; Circulating Cancer Biomarkers Lab, SiRIC, Translational Research Department, Institut Curie, Paris, France.
  • Decraene C; Circulating Cancer Biomarkers Lab, SiRIC, Translational Research Department, Institut Curie, Paris, France; CNRS UMR144, Institut Curie, Paris, France.
  • Bernard V; ICGex NGS Platform, Institut Curie, Paris, France.
  • Kamal M; Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud, France.
  • Blin A; ICGex NGS Platform, Institut Curie, Paris, France.
  • Leroy Q; ICGex NGS Platform, Institut Curie, Paris, France.
  • Rio Frio T; ICGex NGS Platform, Institut Curie, Paris, France.
  • Pierron G; Oncogenetic Laboratory, Institut Curie, Paris, France.
  • Callens C; Oncogenetic Laboratory, Institut Curie, Paris, France.
  • Bieche I; Oncogenetic Laboratory, Institut Curie, Paris, France.
  • Saliou A; Circulating Cancer Biomarkers Lab, SiRIC, Translational Research Department, Institut Curie, Paris, France.
  • Madic J; Circulating Cancer Biomarkers Lab, SiRIC, Translational Research Department, Institut Curie, Paris, France.
  • Rouleau E; Oncogenetic Laboratory, Institut Curie, Paris, France.
  • Bidard FC; Circulating Cancer Biomarkers Lab, SiRIC, Translational Research Department, Institut Curie, Paris, France; Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud, France.
  • Lantz O; INSERM U932, Institut Curie, Paris, France; CIC-BT-507, Institut Curie, Paris, France.
  • Stern MH; INSERM U830, Institut Curie, Paris, France.
  • Le Tourneau C; Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud, France; INSERM U900, Institut Curie, Paris, France.
  • Pierga JY; Circulating Cancer Biomarkers Lab, SiRIC, Translational Research Department, Institut Curie, Paris, France; Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud, France; University Paris Descartes, Paris, France. Electronic address: jean-yves.pierga@curie.fr.
Mol Oncol ; 9(4): 783-90, 2015 Apr.
Article en En | MEDLINE | ID: mdl-25579085
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN de Neoplasias / Medicina de Precisión / Técnicas de Genotipaje / Células Neoplásicas Circulantes / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN de Neoplasias / Medicina de Precisión / Técnicas de Genotipaje / Células Neoplásicas Circulantes / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos